1-5 of 5
Authors: Mark I Berge Henegouwen
Journal Article
218. INITIAL EXPERIENCES WITH VACUUM-STENT AS NOVEL TREATMENT OPTION FOR TRANSMURAL DEFECTS IN THE UPPER GASTRO-INTESTINAL TRACT: A SINGLE-CENTER CASE SERIES Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.071, https://doi.org/10.1093/dote/doad052.071
Published: 30 August 2023
Journal Article
143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY Free
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.024, https://doi.org/10.1093/dote/doad052.024
Published: 30 August 2023
Journal Article
792 OUTCOMES AFTER TOTALLY MINIMALLY INVASIVE VERSUS HYBRID OR OPEN IVOR LEWIS ESOPHAGECTOMY: RESULTS FROM THE INTERNATIONAL ESODATA STUDY GROUP. Free
Diseases of the Esophagus, Volume 34, Issue Supplement_1, September 2021, doab052.792, https://doi.org/10.1093/dote/doab052.792
Published: 17 September 2021
Journal Article
729 RELATION OF POSTOPERATIVE MORBIDITY WITH QUALITY OF LIFE FOLLOWING ESOPHAGEAL SURGERY FOR CANCER: A EUROPEAN MULTICENTER STUDY Free
Diseases of the Esophagus, Volume 34, Issue Supplement_1, September 2021, doab052.729, https://doi.org/10.1093/dote/doab052.729
Published: 17 September 2021
Journal Article
736 PL11.04 HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH ESOPHAGEAL CANCER FOLLOWING ESOPHAGECTOMY TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY OR CHEMOTHERAPY: EUROPEAN MULTICENTER STUDY Free
Diseases of the Esophagus, Volume 34, Issue Supplement_1, September 2021, doab052.736, https://doi.org/10.1093/dote/doab052.736
Published: 17 September 2021
